X-PUR¿
Natural health product licensed in Canada
- Licence holder
- Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
- NPN or DIN-HM
- 80030883
- Status
- Active licence
- Licence date
- 27 March 2012
- Revision date
- Not provided
- Form
- Pâte
- Route of administration
- Dentaire
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Calcium sodium phosphosilicate Source : Dioxyde de silicium | 5 % (p/p) |
| Calcium sodium phosphosilicate Source : Dioxyde de silicium | Not specified |
| Calcium sodium phosphosilicate Source : Sodium oxide | 5 % (p/p) |
| Calcium sodium phosphosilicate Source : Sodium oxide | Not specified |
| Calcium sodium phosphosilicate Source : Phosphorus pentoxide | 5 % (p/p) |
| Calcium sodium phosphosilicate Source : Phosphorus pentoxide | Not specified |
| Calcium sodium phosphosilicate Source : Oxyde de calcium | 5 % (p/p) |
| Calcium sodium phosphosilicate Source : Oxyde de calcium | Not specified |
Non-medicinal ingredients
silice, sulfate sodique de lauryle, Spearmint oil, Poly(éthylène glycol), Huile de menthe poivrée, Glycérine, Potassium acesulfame, Carbomer 910, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Paste | maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides relief from dental hypersensitivity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030883
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.